GH1 and acromegaly: The predictive role of age, tumor size, as well as pre-operative GH and IGF-1 levels on remission outcomes are reported in previous studies, and some studies suggested that the clinicopathological information of acromegaly patients may be able to predict the success rate of treatment which provide individualized modalities in therapeutic process [7].